AstraZeneca shared on LinkedIn:
“What could happen when policy interventions focus on improved detection and treatment of chronic kidney disease (CKD)?
Modelling across eight countries predicts these measures can help people with CKD live healthier lives, while supporting long-term economic productivity and workforce participation.
Explore the evidence on the Make the Change For Kidney Health website.”
AstraZeneca shared modeling projections from eight countries showing that policy efforts aimed at better detection and treatment of chronic kidney disease (CKD) can enhance patient outcomes and promote economic productivity.
Find More Posts Featuring AstraZeneca on OncoDaily.